You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》高盛首予康聖環球(09960.HK)「買入」評級 目標價13元
阿思達克 08-18 13:09
高盛發表研究報告,首予康聖環球(09960.HK)「買入」評級,目標價13元。報告稱,公司具規模模式由血液學擴大至其他專科。康聖環球是獨立臨床實驗室(ICL)特檢的先行者,在中國ICL行業間具最大特檢組合,覆蓋逾3,500種測試品,作全方位樣本分析。它在一些領域具主導地位,例如是內地最大血液學特檢服務商,以收入計去年市佔達42%。公司亦計劃擴展至更多專科,如基因及罕有病、傳染病、腫瘤、神經病學等,並擬擴展至海外市場。 由於人口老化及人民對健康日趨關注,以及對診斷準確度要求提升,該行引述市場分析指,料內地特檢市場在2020至2025年間年均複合增長達7%,形容具龐大潛力。此外,高盛料更多臨床測試服務將由醫院外判至ICL,源於成本優勢及監管支持。高盛稱,康聖環球已準備好迎接增長,具備先進技術平台,進行綜合測試;在多個專科具高度規模經營模式,有良好往績;具研發能力及廣泛臨床數據庫;在產能及品控而言具備實驗室能力;以及管理層具經驗,有強大投資者支持。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account